Antibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancer

Published:2018-08 Issue: Volume:89 Page:328-335
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Yang Wentao,Hu Qian,Xu Yanmei,Liu Hailang,Zhong Lin

Funder

Natural Science Foundation of Jiangxi Province

The Science and Technology Support Program of Jiangxi Province

Publisher

Elsevier BV

Subject

Biomaterials,Bioengineering,Mechanics of Materials

Reference26 articles.

1. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma;Berger;Ann. Surg. Oncol.,2004

2. Cancer in the elderly: pancreatic cancer;Shore;Surg. Oncol.,2004

3. Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer;Kattel;Br. J. Clin. Pharmacol.,2015

4. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer;Singh;Oncogene,2010

5. Pancreatic cancer: understanding and overcoming chemoresistance;Wang;Nat. Rev. Gastroenterol. Hepatol.,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma;Materials Today Bio;2024-10

2. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles;Life;2024-04-10

3. Recent Developments in Nanotechnology and Immunotherapy for the Diagnosis and Treatment of Pancreatic Cancer;Current Pharmaceutical Biotechnology;2024-02-23

4. Liposome- and niosome-based drug delivery for pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

5. Anti-CD4 antibody and dendrimeric peptide based targeted nano-liposomal dual drug formulation for the treatment of HIV infection;Life Sciences;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3